Browsing Tag
Rinvoq
1 post
Phase III Rinvoq Win in Crohn’s; Meat After CRC Dx? Kidney Disease and Cirrhosis
Another phase III study of upadacitinib (Rinvoq) induction in moderate to severe Crohn's disease showed significantly improved rates of clinical remission and endoscopic response with the JAK inhibitor versus placebo among individuals who failed on conventional or biologic therapies, drugmaker AbbVie said. Meanwhile, Janssen announced that a phase IIb trial of its IL-23 blocker guselkumab…